Skip to content

Clinical trials

Phase 1/2 Lung Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1/2 Country / region: Netherlands Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20112
20172
20191
20211
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Revolution Medicines, Inc.2
AbbVie (prior sponsor, Abbott)1
BBB-Therapeutics B.V.1
Bristol-Myers Squibb1
Hoffmann-La Roche1
Maastricht Radiation Oncology1
Mural Oncology, Inc1
Novartis Pharmaceuticals1
The Netherlands Cancer Institute1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms11
Carcinoma, Non-Small-Cell Lung9
Neoplasms6
Neoplasms by Site4
Adenocarcinoma3
Bronchial Neoplasms3
Colonic Neoplasms3
Colorectal Neoplasms3
Gastrointestinal Neoplasms3
Intestinal Neoplasms3

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.